Acute Spinal Cord Injury Clinical Trial
Official title:
Pilot Study on the Effect of Early FES Cycling After Acute Spinal Cord Injury on Neuromuscular Preservation and Neurorecovery
Verified date | February 2024 |
Source | University of Alberta |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Spinal cord injury (SCI) is a devastating condition that often leads to paralysis and multiple health problems such as muscle wasting, bone loss and spasticity. Despite the paralysis, functional electrical stimulation (FES) on the skin surface muscles may produce muscle contractions. People who have had an SCI for a long time (chronic SCI) already use FES cycling to exercise, and it is known that it can reverse muscle atrophy and has a wide range of health benefits. Furthermore, animal research suggests that starting exercise training early after new SCI may promote spinal cord recovery. However, not much is known about early FES cycling in humans. Therefore, the investigators propose to study if early FES cycling could prevent muscle wasting, pain or spasticity, and help with spinal cord recovery. The study will recruit 36 participants with a new, acute SCI, between 14 and 21 days after their injury into 3 groups. An Early-FES group starts FES cycling early after injury (between 14 and 21 days after injury), and for a duration of 6 months. A Delayed-FES group starts FES cycling 3 months after enrolling in the study, and for a duration of 3 months. A Control group does not perform FES cycling. This pilot study will allow us to study if early FES cycling, in addition to normal care, has greater benefits on the preservation and recovery of the leg muscles and spinal cord function than delayed FES cycling or standard care only. The results of this pilot study may lead to the development of a larger study with early FES cycling after new SCI.
Status | Completed |
Enrollment | 35 |
Est. completion date | October 31, 2023 |
Est. primary completion date | August 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Traumatic or non-traumatic SCI - Acute onset of SCI - Able to start FES cycling 14-21 days post injury - Injury level C1 - L5 - AIS A, B, C, D (ASIA Impairment Scale) - Medically stable Absolute Contraindications and Exclusion Criteria 1. AIS D, able to walk without assistive device 2. Unstable spine fractures 3. Unstable fractures/dislocations in lower extremities or pelvis 4. Pregnancy 5. Unable to give consent to participate in the study 6. Contraindications for TMS (Transcranial Magnetic Stimulation). Relative Contraindications and Exclusion Criteria (Exclusion or Caution) 1. Lower motor neuron injury with insufficient muscle contraction with FES 2. Peripheral nerve or root injury resulting in denervated lower limb muscles 3. History of severe hip or knee instability or dislocation/subluxation 4. Osteoporosis in lower extremities that could result in fracture from cycling 5. Osteoarthritis in lower extremities 6. Limited range of motion in hip and knee preventing cycling 7. History of epilepsy not effectively managed by medication 8. History of heart problems (coronary artery disease / myocardial infarction / congestive heart failure) 9. Implanted cardiac demand pacemaker 10. Implanted stimulators: diaphragmatic, epidural, vagus nerve, phrenic 11. Malignant tumor in stimulated areas 12. Thrombophlebitis or thrombosis in stimulated area 13. Skin lesions or open wounds at any potential electrode site 14. Pressure ulcers that could deteriorate from cycling 15. Spasticity 16. Autonomic dysreflexia 17. Active heterotopic ossification in lower extremities 18. Extreme edema or adipose tissue in legs 19. Any other contraindications to participate in an active exercise program |
Country | Name | City | State |
---|---|---|---|
Canada | University of Alberta | Edmonton | Alberta |
Lead Sponsor | Collaborator |
---|---|
University of Alberta | Glenrose Foundation, Royal Alexandra Hospital |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Muscle cross-sectional area thigh and calf: Change from 0 to 3 months | Muscle cross sectional area measured from multiple transverse CT scan slices across thigh and calf | 3 months | |
Primary | Muscle cross-sectional area thigh and calf: Change from 3 months to 6 months | Muscle cross sectional area measured from multiple transverse CT scan slices across thigh and calf | 3 months | |
Primary | Spasticity legs: Change from 0 to 3 months | Size of the cutaneomuscular reflex (CMR) produced by electrical stimulation of the medial arch of the foot and measured in the electromyogram (EMG) from several muscles in the leg (tibialis anterior, soleus, quadriceps and hamstrings). | 3 months | |
Primary | Spasticity legs: Change from 3 months to 6 months | Size of the cutaneomuscular reflex (CMR) produced by electrical stimulation of the medial arch of the foot and measured in the electromyogram (EMG) from several muscles in the leg (tibialis anterior, soleus, quadriceps and hamstrings). | 3 months | |
Primary | Corticospinal excitability: Change from 0 to 3 months | Size of the motor evoke potentials (MEP) produced by transcranial magnetic stimulation of the motor cortex, and measured in the EMG of several leg muscles (tibialis anterior, soleus, quadriceps and hamstrings). | 3 months | |
Primary | Corticospinal excitability: Change from 3 months to 6 months | Size of the motor evoke potentials (MEP) produced by transcranial magnetic stimulation of the motor cortex, and measured in the EMG of several leg muscles (tibialis anterior, soleus, quadriceps and hamstrings). | 3 months | |
Primary | Spinal cord excitability: Change from 0 to 3 months | Hmax/Mmax ratio, based on H-reflex and M-wave measurements in soleus EMG during tibial nerve stimulation, will be quantified as a measure of general spinal cord excitability (sensory transmission and motoneuron excitability) | 3 months | |
Primary | Spinal cord excitability: Change from 3 months to 6 months | Hmax/Mmax ratio, based on H-reflex and M-wave measurements in soleus EMG during tibial nerve stimulation, will be quantified as a measure of general spinal cord excitability (sensory transmission and motoneuron excitability) | 3 months | |
Primary | Muscle strength: Change from 0 to 3 months | Size of the EMG measured during maximum voluntary contraction in tibialis anterior, soleus, quadriceps and hamstrings. | 3 months | |
Primary | Muscle strength: Change from 3 months to 6 months | Size of the EMG measured during maximum voluntary contraction in tibialis anterior, soleus, quadriceps and hamstrings. | 3 months | |
Secondary | SCI Classification at Baseline | Spinal cord injury classification based on the American Spinal Injury Association (ASIA) Injury Scale (AIS), according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range AIS A, B, C, D (most-least severe injury) | Baseline | |
Secondary | SCI Classification at 3 months | Spinal cord injury classification based on the American Spinal Injury Association (ASIA) Injury Scale (AIS), according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range AIS A, B, C, D (most-least severe injury) | 3 months | |
Secondary | SCI Classification at 6 months | Spinal cord injury classification based on the American Spinal Injury Association (ASIA) Injury Scale (AIS), according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range AIS A, B, C, D (most-least severe injury) | 6 months | |
Secondary | Motor scores: Change from 0 to 3 months | Sum of motor scores based on manual muscle strength testing of 5 key upper limb and 5 key lower limb muscle groups bilaterally according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range worst-best score 0-100. | 3 months | |
Secondary | Motor scores: Change from 3 months to 6 months | Sum of motor scores based on manual muscle strength testing of 5 key upper limb and 5 key lower limb muscle groups bilaterally according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range worst-best score 0-100. | 3 months | |
Secondary | Sensory scores: Change from 0 to 3 months | Sum of sensory scores in response to light touch and pinprick at 28 key sensory points on each side of the whole body, according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range worst-best score 0-224. | 3 months | |
Secondary | Sensory scores: Change from 3 months to 6 months | Sum of sensory scores in response to light touch and pinprick at 28 key sensory points on each side of the whole body, according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range worst-best score 0-224. | 3 months | |
Secondary | Pain intensity: Change from 0 to 3 months | Pain intensity assessment using the International Spinal Cord Injury Pain Basic Data Set v2. The tool scores intensity using an 11-point numeric scale (Range best-worst score 0-10). In addition the tool describes pain over the previous 7 days, impact of pain, type of pain (nociceptive vs. neuropathic), intensity and duration of pain, and treatment for pain. | 3 months | |
Secondary | Pain intensity: Change from 3 months to 6 months | Pain intensity assessment using the International Spinal Cord Injury Pain Basic Data Set v2. The tool scores intensity using an 11-point numeric scale (Range best-worst score 0-10). In addition the tool describes pain over the previous 7 days, impact of pain, type of pain (nociceptive vs. neuropathic), intensity and duration of pain, and treatment for pain. | 3 months | |
Secondary | Leg cross-sectional area thigh and calf: Change from 0 to 3 months | Leg cross-sectional area calculated based on circumferences of thigh and calf measured with tape measure, and corrected for skinfold thickness (measure of subcutaneous fat) measured with skinfold caliper at same locations. | 3 months | |
Secondary | Leg cross-sectional area thigh and calf: Change from 3 months to 6 months | Leg cross-sectional area calculated based on circumferences of thigh and calf measured with tape measure, and corrected for skinfold thickness (measure of subcutaneous fat) measured with skinfold caliper at same locations. | 3 months | |
Secondary | Walking Speed: Change from 0 to 3 months | Depending in the participant's capabilities, walking speed will be assessed with the 10-meter walking test (measuring time taken to walk 10 meters), and/or the 6-minute walking test (measuring distance walked in 6 minutes) | 3 months | |
Secondary | Walking Speed: Change from 3 months to 6 months | Depending in the participant's capabilities, walking speed will be assessed with the 10-meter walking test (measuring time taken to walk 10 meters), and/or the 6-minute walking test (measuring distance walked in 6 minutes) | 3 months | |
Secondary | Walking Capability: Change from 0 to 3 months | Scored using the Walking Index for Spinal Cord Injury (WISCI II), giving a ranking from most severe impairment (0) to least severe impairment (20) based on the use of devices, braces and physical assistance of one or more persons. | 3 months | |
Secondary | Walking Capability: Change from 3 months to 6 months | Scored using the Walking Index for Spinal Cord Injury (WISCI II), giving a ranking from most severe impairment (0) to least severe impairment (20) based on the use of devices, braces and physical assistance of one or more persons. | 3 months | |
Secondary | Spasticity self-report: Change from 0 to 3 months | Frequency and severity of the spasticity, its interference with function, and association with pain, scored using 11-point numeric scales. Range 0-10, with best (0) to worst (10). | 3 months | |
Secondary | Spasticity self-report: Change from 3 months to 6 months | Frequency and severity of the spasticity, its interference with function, and association with pain, scored using 11-point numeric scales. Range 0-10, with best (0) to worst score (10). | 3 months | |
Secondary | Depression at 3 months | Total score derived from the Patient Health Questionnaire (PHQ-9 ) which includes 9 questions related to signs of depression. Range best-worst score 0-27. | 3 months | |
Secondary | Depression at 6 months | Total score derived from the Patient Health Questionnaire (PHQ-9 ) which includes 9 questions related to signs of depression. Range best-worst score 0-27. | 6 months | |
Secondary | Psychosocial status of participants as assessed by AQol-8D at 3 months | Total score derived from the Assessment of Quality of Life (AQol-8D), measuring 8 dimensions of quality of life. Range worst-best score 35-176.
Score derived from EQ-5D-5L Quality of Life Tool (EuroQol Research Foundation), measuring 5 dimensions. Range best-worst score 5-25. |
3 months | |
Secondary | Psychosocial status of participants as assessed by AQol-8D at 6 months | Total score derived from the Assessment of Quality of Life (AQol-8D), measuring 8 dimensions of quality of life. Range worst-best score 35-176.
Score derived from EQ-5D-5L Quality of Life Tool (EuroQol Research Foundation), measuring 5 dimensions. Range best-worst score 5-25. |
6 months | |
Secondary | Program Cost | Cost and health care resources for the administration of early and delayed FES | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04811235 -
Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
|
N/A | |
Completed |
NCT00406016 -
Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI
|
Phase 1 | |
Recruiting |
NCT05305118 -
TSCS for Acute SCI
|
N/A | |
Recruiting |
NCT05244408 -
"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
|
||
Recruiting |
NCT05731986 -
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
|
N/A | |
Recruiting |
NCT06452264 -
Early Intervention for Information Processing Speed Deficits in Acute SCI: A Pilot Study
|
N/A | |
Recruiting |
NCT05426681 -
Spinal Cord Injury Neuroprotection With Glyburide
|
Phase 1 | |
Recruiting |
NCT04056988 -
tSCI Contrast Enhanced Ultrasound Study
|
Phase 4 | |
Recruiting |
NCT05745298 -
The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury
|
N/A | |
Terminated |
NCT01750684 -
AC105 in Patients With Acute Traumatic Spinal Cord Injury
|
Phase 2 | |
Recruiting |
NCT04475224 -
Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury
|
Phase 3 | |
Enrolling by invitation |
NCT06030531 -
Spasticity and Functional Recovery After SCI
|
||
Active, not recruiting |
NCT03935724 -
Stem Cells in Spinal Cord Injury
|
Phase 2/Phase 3 | |
Recruiting |
NCT04054414 -
PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury
|
Phase 2 | |
Recruiting |
NCT06000592 -
Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI
|
N/A | |
Completed |
NCT02325414 -
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
|
Phase 2 | |
Recruiting |
NCT02034669 -
Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment
|
Phase 1/Phase 2 | |
Terminated |
NCT02232165 -
Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury
|
N/A | |
Completed |
NCT02260713 -
Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study.
|
Phase 1/Phase 2 | |
Terminated |
NCT02524379 -
Spinal Cord Injury Neuroprotection With Glyburide
|
Phase 1/Phase 2 |